In HD patients, newly generated neurons display early maturation impairments, morphological abnormalities, and reduced expression of NeuN [13], consistent with the observed impairments in AHN in transgenic HD mouse models [48]. This evidence concerns the gene RBFOX3 and Huntington disease.